Gaurav Bissa of LKP Securities told CNBC-TV18, "The entire pharma space especially midcap pharma space has been buzzing. Glenmark Pharma has been one of the underperformers so far, it has now started witnessing a bounce back again. Today the intraday long positions are clearly evident in the stock. Another interesting factor was the 860 strike Call option was witnessing huge amount of activity."
"I recommend going long on 860 Call option for target of Rs 30 and above with a stop loss at Rs 8," he added.
Disclosure: Analyst has no personal holdings in the stock but it is possible that he may have recommended them to his clients at LKP Securities.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
